Deutsche Bank Downgrades AstraZeneca (AZN) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Deutsche Bank Downgrades AstraZeneca (AZN:LN) (AZN) to Sell
February 8, 2024 5:36 AM ESTDeutsche Bank analyst Emmanuel Papadakis downgraded AstraZeneca (AZN:LN) (NASDAQ: AZN) from Hold to Sell with a price target of GBP95.00 (from GBP110.00).
... MoreAstraZeneca (AZN) Tops Q4 EPS by 71c; initiates guidance
February 8, 2024 2:55 AM ESTAstraZeneca (NASDAQ: AZN) reported Q4 EPS of $1.45, $0.71 better than the analyst estimate of $0.74. Revenue for the quarter came in at $12.02 billion versus the consensus estimate of $12 billion.
GUIDANCE:
The Company issues its Total Revenue and Core EPS guidance for... More
SOPHiA GENETICS (SOPH) and AstraZeneca Spain (AZN) Commit to Increasing Ovarian Cancer Testing in Spain
February 7, 2024 6:53 AM ESTSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it has expanded an existing program in Spain to increase access to local testing for homologous recombination deficiency (HRD) throughout the country. The expansion of the program, supported by AstraZeneca (NASDAQ: AZN) Spain and its network throughout the country, will further SOPHiA GENETICS' commitment to global health... More
